|
|
MedCalc citations database
Alimentary Pharmacology & TherapeuticsPapers that cite MedCalc:
Vannella L, Lahner E, Osborn J, Cesare B, Massimo M, Delle Fave G, Annibale B.
Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis.
Alimentary Pharmacology & Therapeutics, 2010;31:1042-1050. [Abstract]
Department of Digestive and Liver Disease, Sant'Andrea Hospital, II School of Medicine, University Sapienza of Rome, Italy.
Giannini EG, Basso M, Savarino V, Picciotto A.
Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients.
Alimentary Pharmacology & Therapeutics, 2010;31:502-508. [Abstract]
Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Genoa, Italy.
Oussalah A, Roblin X, Laharie D, Filippi J, Flamant M, Faure P, Phelip JM, Bigard MA, Peyrin-Biroulet L.
Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey.
Alimentary Pharmacology & Therapeutics, 2009;30:854-863. [Abstract]
nserm, U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
Daperno M, Sostegni R, Canaparo R, Serpe L, Lavagna A, Crocellà L, Castagno F, Vernetto A, Rigazio C, Ercole E, D'Antico S, Pera A, Zara G, Rocca R.
Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.
Alimentary Pharmacology & Therapeutics, 2009;30:843-853. [Abstract]
Gastroenterology Division, A.O. Ordine Mauriziano, Torino, Italy.
Bouguen G, Trouilloud I, Siproudhis L, Oussalah A, Bigard MA, Bretagne JF, Peyrin-Biroulet L.
Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximab.
Alimentary Pharmacology & Therapeutics, 2009;30:749-756. [Abstract]
Department of Hepato-Gastroenterology, University Hospital of Rennes, Pontchaillou, France.
Lahner E, Annibale B, Delle Fave G.
Systematic review: impaired drug absorption related to the co-administration of antisecretory therapy.
Alimentary Pharmacology & Therapeutics, 2009;29:1219-1229. [Abstract]
Digestive and Liver Disease Unit, 2nd School of Medicine, University La Sapienza, Rome, Italy.
Garud S, Leffler D, Dennis M, Edwards-George J, Saryan D, Sheth S, Schuppan D, Jamma S, Kelly CP.
Interaction between psychiatric and autoimmune disorders in celiac disease patients in the Northeastern United States.
Alimentary Pharmacology & Therapeutics, 2009;29:898-905. [Abstract]
The Celiac Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Oussalah A, Babouri A, Chevaux JB, Stancu L, Trouilloud I, Bensenane M, Boucekkine T, Bigard MA, Peyrin-Biroulet L.
Adalimumab for Crohn's disease with intolerance or lost response to infliximab: a 3-year single-centre experience.
Alimentary Pharmacology & Therapeutics, 2009;29:416-423. [Abstract]
Inserm, U724, and Department of Hepato-Gastroenterology, University Hospital of Nancy, Vandoeuvre-les-Nancy, France.
Lahner E, Corleto VD, D'Ambra G, Di Giulio E, Delle Fave G, Annibale B.
Is interleukin-1 genotyping useful for the clinical management of patients with atrophic body gastritis?
Alimentary Pharmacology & Therapeutics, 2008;27:355-365. [Abstract]
Digestive and Liver Disease Unit, 2nd Medical School, University La Sapienza, Rome, Italy.
Schröder O, Naumann M, Shastri Y, Povse N, Stein J.
Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
Alimentary Pharmacology & Therapeutics, 2007;26:1035-1042. [Abstract]
1st Department of Internal Medicine-ZAFES, J.W. Goethe-University, Frankfurt am Main, Germany.
Kohn A, Daperno M, Armuzzi A, Cappello M, Biancone L, Orlando A, Viscido A, Annese V, Riegler G, Meucci G, Marrollo M, Sostegni R, Gasbarrini A, Peralta S, Prantera C.
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.
Alimentary Pharmacology & Therapeutics, 2007;26:747-756. [Abstract]
Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.
Tandon P, Bain VG, Tsuyuki RT, Klarenbach S.
Systematic review: renal and other clinically relevant outcomes in hepatorenal syndrome trials.
Alimentary Pharmacology & Therapeutics, 2007;25:1017-1028. [Abstract]
Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Capurso G, Carnuccio A, Lahner E, Panzuto F, Baccini F, Fave GD, Annibale B.
Corpus-predominant gastritis as a risk factor for false-negative C-urea breath test results.
Alimentary Pharmacology & Therapeutics, 2006;24:1543-1460. [Abstract]
Digestive and Liver Disease Unit, S. Andrea Hospital, II Medical School, University 'La Sapienza', Roma, Italy.
Baccini F, Aloe Spiriti MA, Vannella L, Monarca B, Delle Fave G, Annibale B.
Unawareness of gastrointestinal symptomatology in adult coeliac patients with unexplained iron-deficiency anaemia presentation.
Alimentary Pharmacology & Therapeutics, 2006;23:915-921. [Abstract]
Digestive and Liver Disease Unit, University 'La Sapienza', Rome, Italy.
Panzuto F, Di Giulio E, Capurso G, Baccini F, D'Ambra G, Delle Fave G, Annibale B
Large hiatal hernia in patients with iron deficiency anaemia: a prospective study on prevalence and treatment.
Alimentary Pharmacology & Therapeutics, 2004;19:663-670. [Abstract]
Department of Digestive and Liver Disease, II School of Medicine, University La Sapienza, Rome, Italy
Apolinario A, Diago M, Lo Iacono O, Lorente R, Perez C, Majano PL, Clemente G, Garcia-Monzon C
Increased circulating and intrahepatic T-cell-specific chemokines in chronic hepatitis C: relationship with the type of virological response to peginterferon plus ribavirin combination therapy.
Alimentary Pharmacology & Therapeutics, 2004;19:551-562. [Abstract]
Instituto de Hepatologia Clinica-Experimental y Trasplante Hepatico, Hospital General Universitario Gregorio Maranon-Santa Cristina, Madrid, Spain
Testa R, Testa E, Giannini E, Botta F, Malfatti F, Chiarbonello B, Fumagalli A, Polegato S, Podesta E, Romagnoli P, Risso D, Cittadini G, De Caro G.
Trans-catheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-stage Liver Disease (MELD), in predicting outcome after treatment.
Alimentary Pharmacology & Therapeutics, 2003;17:1563-1569. [Abstract]
Gastroenterology Unit and Postgraduate School of Gastroenterology and Digestive Endoscopy, Department of Internal Medicine, University of Genoa, Genoa, Italy
Van Vlierberghe H, Verdievel H, Colle I, Delanghe J, Praet M, Bernard D, Leroux-Roels G, De Vos M
Non-transferrin-bound iron in untreated and ribavirin-treated chronic hepatitis C patients.
Alimentary Pharmacology & Therapeutics, 2002;16:1555-1562. [Abstract]
Departments of Gastroenterology, Ghent University Hospital, Ghent, Belgium
Giannini E, Fasoli A, Borro P, Chiarbonello B, Malfatti F, Romagnoli P, Botta F, Testa E, Fumagalli A, Polegato S, Savarino V, Testa R
Impairment of cytochrome P-450-dependent liver activity in cirrhotic patients with Helicobacter pylori infection.
Alimentary Pharmacology & Therapeutics, 2001;15:1967-1973. [Abstract]
Gastroenterology Unit and Postgraduate School of Gastroenterology and Digestive Endoscopy, Department of Internal Medicine, University of Genoa, Italy
Lo Iacono O, Garcia-Monzon C, Almasio P, Garcia-Buey L, Craxi A, Moreno-Otero R
Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon-alpha.
Alimentary Pharmacology & Therapeutics, 1998;12:1091-1099. [Abstract]
Liver Unit, Hospital de la Princesa, Universidad Autonoma de Madrid, Spain
Submit
Submit a publication to the database.
|
